Author: Zacks Small Cap Research

1 29 30 31 32 33 35 310 / 343 POSTS
By Brian Marckx, CFA NASDAQ:CEMI MODEL ADJUSTMENTS FOR $8.5M FIOCRUZ ORDER, UNICEF RFP AWARD (UP TO $4.9M)New $8.5M DPP HIV, Leishmania Order From Brazil Prompts Upward Revision to Estimated 2018 Revenue…Earlier this week (Dec 5th) Chembio (NASDAQ:CE ...
NASDAQ:CKPT Checkpoint Therapeutics (NASDAQ:CKPT) boasts an impressive portfolio of immuno-oncology and anti-cancer agents that have the potential for approvals as both mono- and combination therapies.  Checkpoint has six compounds in devel ...
By Lisa Thompson NASDAQ:PIXY Last night, ShiftPixy (NASDAQ:PIXY) filed a Form 12b-25 Notification of Late Filing, for its 10K for the year ending August 31, 2017. The company now has 15 days to finish its audit, (which it believes will be issued with ...
By Brian Marckx, CFA NASDAQ:SBOT Stellar Biotech (NASDAQ:SBOT) Recent Operational Highlights:  Recent highlights on the operational front include • Enrollment of Neovacs' Phase IIb Lupus study completed in July • Neovacs shooting for data ...
By David Bautz, PhD NASDAQ:MTFN Business UpdateMotif Bio Plc (NASDAQ:MTFB) is a biopharmaceutical company focused on the development of antibiotic compounds for difficult to treat bacterial infections. The company’s lead asset, iclaprim, is a novel d ...
By Brian Marckx, CFA OTC:SNWV Q3 Results, Operational Update: Another Top-Line Dud But We Still Expect OUS Adoption To Improve….SANUWAVE (OTC:SNWV) reported Q3 financial results and provided a business update.  Similar to the first two quarters ...
1 29 30 31 32 33 35 310 / 343 POSTS